Malik Aliyah, Shetty Hitesh, Oliver Dominic, Reilly Thomas J, Di Forti Marta, McGuire Philip, Chesney Edward
Department of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.
South London and Maudsley NHS Foundation Trust, London, United Kingdom.
JAMA Psychiatry. 2025 Jun 11. doi: 10.1001/jamapsychiatry.2025.1216.
Cannabis use is common in people with severe mental illness and its adverse effects on outcomes are well established. However, adverse outcomes may also result from cannabis withdrawal syndrome (CWS). CWS includes symptoms such as agitation, irritability, and aggression, and typically peaks after 3 to 5 days of abstinence.
To assess whether cannabis use prior to admission is associated with an increase in the risk of transfer to a psychiatric intensive care unit (PICU) during the cannabis withdrawal risk period.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used clinical data from a secondary mental health care database and took place at 4 psychiatric hospitals in London, United Kingdom, between January 2008 and December 2023. Patients included adults admitted to general psychiatric wards and PICUs. Data were analyzed from June 2023 to February 2025.
Cannabis use was determined from clinical records, using natural language processing and manual review.
The primary outcome was transfer from a general ward to PICU during the cannabis withdrawal risk period (3 to 5 days after presentation to the hospital). Secondary outcomes included admission to PICU at any time point. Outcomes were analyzed according to cannabis use status with multivariable models, which adjusted for age, gender, ethnicity, diagnosis, tobacco use, stimulant use, comorbid alcohol or substance use disorder, and admission year.
There were 52 088 hospital admissions identified, of which 4691 involved admission to a PICU (9.0%). Cannabis users were more likely to be admitted to a PICU than nonusers (adjusted odds ratio [aOR], 1.44; 95% CI, 1.33-1.55; P < .001). There were 1236 admissions where the patient was transferred to PICU after initial admission to a general ward (mean [SD] age, 33.4 [10.4] years; 810 male [66%] and 426 female [34%]). At 3 to 5 days postpresentation (the risk period for cannabis withdrawal), transfer from a general ward to a PICU was more common in cannabis users (31.0%) than nonusers (24.2%) (aOR, 1.36; 95% CI, 1.01-1.81; P = .04). The association was particularly evident in women (aOR, 2.03; 95% CI, 1.22-3.39; P = .007) and in those older than 35 years (aOR, 2.53; 95%CI: 1.52-4.21; P < .001).
People with severe mental illness who are cannabis users may develop cannabis withdrawal syndrome shortly after hospital admission, and this can exacerbate their mental state.
大麻使用在重度精神疾病患者中很常见,其对治疗结果的不良影响已得到充分证实。然而,大麻戒断综合征(CWS)也可能导致不良后果。CWS包括激动、易怒和攻击性等症状,通常在戒断3至5天后达到高峰。
评估入院前使用大麻是否与在大麻戒断风险期转至精神科重症监护病房(PICU)的风险增加有关。
设计、设置和参与者:这项回顾性队列研究使用了二级精神卫生保健数据库中的临床数据,于2008年1月至2023年12月在英国伦敦的4家精神病医院进行。患者包括入住普通精神科病房和PICU的成年人。数据于2023年6月至2025年2月进行分析。
通过自然语言处理和人工审核从临床记录中确定大麻使用情况。
主要结局是在大麻戒断风险期(入院后3至5天)从普通病房转至PICU。次要结局包括在任何时间点入住PICU。根据大麻使用状况,使用多变量模型分析结局,该模型对年龄、性别、种族、诊断、烟草使用、兴奋剂使用、合并酒精或物质使用障碍以及入院年份进行了调整。
共确定了52088例住院病例,其中4691例涉及入住PICU(9.0%)。大麻使用者比非使用者更有可能入住PICU(调整后的优势比[aOR],1.44;95%置信区间[CI],1.33 - 1.55;P <.001)。有1236例患者在最初入住普通病房后转至PICU(平均[标准差]年龄,33.4[10.4]岁;男性810例[66%],女性426例[34%])。在就诊后3至5天(大麻戒断的风险期),大麻使用者从普通病房转至PICU的情况比非使用者更常见(31.0%对24.2%)(aOR,1.36;95%CI,1.01 - 1.81;P =.04)。这种关联在女性中尤为明显(aOR,2.03;95%CI,1.22 - 3.39;P =.007)以及在35岁以上的人群中(aOR,2.53;95%CI:1.52 - 4.21;P <.001)。
使用大麻的重度精神疾病患者在入院后不久可能会出现大麻戒断综合征,这会加剧他们的精神状态。